Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, has emerged ...

5245502d47422d31343133 Overview of Infliximab and Biosimilars Infliximab, marketed as Remicade, is a monoclonal antibody used to treat various autoimmune disorders, including rheumatoid arthritis ...

Two more women have been hospitalised with suspected botulism as another fights for life, with all three believed to have received unregulated anti-wrinkle injections from the same person.

It’s self-administered as a subcutaneous injection, either daily or three times a week. The newest DMTs are monoclonal antibodies. These treatments target specific molecules within the immune ...